Well, we’ve had a busy start to 2024. Here’s the first look at our new brand identity. We’ve designed it to better reflect what we are, how we think and where we’re going as a global organisation - modern, future-facing and inclusive, with a new tagline that explains our brand promise. Take a look at our new microsite at https://hubs.ly/Q02j75p70 to see the new brand in action and what it means for our clients, our partners and our people. Our full new website will be landing in a few months. We’d love to hear what you think.
Prescient
Business Consulting and Services
London, UK 20,368 followers
See further, go deeper
About us
We’re a global team of bioscience specialists providing integrated, competitive and customer insights driven strategic consultancy across the full drug lifecycle. We build from a foundation of deep science and clinical-based insights. But while science and strategy may underpin our business, what drives it are deep, collaborative relationships. True partnerships. A true partnership involves going further and digging deeper in search of transformational insights, diverse perspectives and industry-challenging ideas – and applying them with real value. This blend of deep relationships, strategic rigour and scientific expertise unlocks the full potential of healthcare innovation. Innovation with the power to significantly improve people’s lives around the world. Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017. For more information, please visit: www.prescienthg.com.
- Website
-
http://www.prescienthg.com
External link for Prescient
- Industry
- Business Consulting and Services
- Company size
- 201-500 employees
- Headquarters
- London, UK
- Type
- Privately Held
- Founded
- 2007
- Specialties
- Product Strategy, Portfolio Strategy, Intelligence, Advisory, Therapeutic Expertise, Commercial Expertise, Clinical Expertise, Competitive Intelligence, Product Differentiation, Oncology, Immunotherapy, Biosimilars, Insights, Portfolio Planning, Clinical Development Strategy, New Product Planning, Value Proposition Development, Launch Strategy, Life Cycle Management, Medical Strategy, Value and Access Strategy, Commercialization Strategy, and Brand Strategy
Locations
Employees at Prescient
Updates
-
We're excited to be exhibiting at the EPHMRA Conference taking place June 24-27 in London. Be sure to visit us and say hi to John Grime, Ishaan Chaudhury and Alex Mole. You can find us at booth #8 on Tuesday and booth #4 on Wednesday. Also, don’t miss our plenary session on Wednesday from 17:20 – 17:55 BST titled 'Shining a Light on the Inequality of Cancer Outcomes'. John Grime, Vice President at Prescient, and Lara Lucchese, Senior Manager, Business Insights & Analytics at BMS, will take to the stage to discuss the challenges of inequalities in cancer treatments and ways to address them. We look forward to seeing you there! #EPHMRA #CancerResearch #HealthcareEquity
-
-
Five years! Congratulations, Hardik Bhatia
-
-
Last week, our London office wrapped up Mental Health Awareness Month with a fun paint and sip event! 🎨 It's not just about the science here; our team is as creative as they come! This gathering was a fantastic reminder of the importance of self-care and embracing our diverse talents. Check out the snapshots below of our colorful creations! #MHAM #TeamBonding
-
-
Five years! Congratulations, Andrea Campi, PhD
-
-
What elements are essential for refining your medical narrative throughout a product's life cycle? Understanding how medical narratives adapt and transform throughout different phases of a product's life cycle and in the face of external events is crucial for effective communication and engagement. Our latest guide, "Navigating Your Medical Narrative: A Proactive Guide" authored by Dr. Olga Fidalgo González, Priyanka Ravikumar, PhD, Dr. Christian Wasmer and Dr. Luke Solon, explores key strategies and the role of real-world evidence and sustainability in enhancing healthcare communication. Download now: https://hubs.ly/Q02zD9DN0 #MedicalNarrative #PharmaStrategy #PharmaLifeCycle
-
-
Five years! Congratulations, Shweta Srivastava
-
-
Ten years! Congratulations, Dr. Ashima Sharma
-
-
Meet the Prescient team at #ASCO2024 to discuss the latest trends in oncology drug development and patient care! Connect directly with Benjamin Doran, Vice President; Swati Anand Kkatyal, Global Head of Insights; Rouzbeh Ahmadian, MD, MS, MBA, Vice President; Dr. Laura M. Darnieder, Director; Conrad Tenenbaum, Ph.D., Director; Lee Griffiths, Director; and Dr Debasish Talukdar, CEO, to learn more about our offerings and how we can help you. #Oncology #Hematology #ClinicalTrials #HealthTechnology #GlobalAccess #OncologyResearch
-
-
Just published! “How Project Optimus has Reshaped Oncology Drug Development: Opportunities and Challenges”, by Divya Walia and Dr. Cameron Mackenzie. Explore the FDA’s strategic shift in dose optimization for oncology drugs and its implications for the industry. https://hubs.ly/Q02ygqPs0 #Oncology #DrugDevelopment #FDA #ProjectOptimus #HealthcareInnovation
-